Loading clinical trials...
Loading clinical trials...
Prospective, Open-label, Multicenter, Initially Single-armed and in Case of Treatment Failure Subsequently Three-armed Randomized Clinical Trial of Phase III/IV Investigating the Escalated Therapy of Scabies With INFECTOSCAB 5% (Permethrin)
Conditions
Interventions
InfectoScab 5 % Creme
Permethrin 10 % Creme
+1 more
Locations
8
Germany
Uniklinik RWTH Aachen
Aachen, Germany
Universitätsklinikum Augsburg
Augsburg, Germany
Klinikum Darmstadt
Darmstadt, Germany
Städtisches Klinikum Dresden
Dresden, Germany
Universitätsklinik und Poliklinik für Dermatologie und Venerologie
Halle, Germany
Klinikum der Stadt Ludwigshafen
Ludwigshafen, Germany
Start Date
June 11, 2021
Primary Completion Date
December 1, 2022
Completion Date
August 1, 2023
Last Updated
August 26, 2021
NCT07305961
NCT06896929
NCT02841215
NCT05819983
NCT05271968
NCT05198947
Lead Sponsor
Infectopharm Arzneimittel GmbH
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions